TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2013-01-18

Name: TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2013-01-18
Creator: TuHURA BIOSCIENCES, INC./NV

What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2013-01-18 (fiscal Q2 2013): 17 published measures, 53 facts as tagged in accession 0001165527-13-000078.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-01-18
Fiscal period: fiscal Q2 2013
Accession: 0001165527-13-000078 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	3,979	USD
At 2012-06-30	1,794	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	19,574	USD
At 2012-06-30	9,984	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	-15,595	USD
At 2012-06-30	-8,190	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2012-12-31	3,979	USD
At 2012-06-30	1,794	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-12-30 to 2012-12-31	-65,008	USD	2
2012-10-01 to 2012-12-31	-3,250	USD	92
2012-07-01 to 2012-12-31	-7,405	USD	184
2009-06-24 to 2012-12-31	-65,008	USD	1287
2011-10-01 to 2011-12-31	-10,916	USD	92
2011-07-01 to 2011-12-31	-14,774	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-5,785	USD	184
2009-06-24 to 2012-12-31	-60,888	USD	1287
2011-07-01 to 2011-12-31	-7,274	USD	184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2012-10-01 to 2012-12-31	USD	92
2012-07-01 to 2012-12-31	USD	184
2009-06-24 to 2012-12-31	USD	1287
2011-10-01 to 2011-12-31	USD	92
2011-07-01 to 2011-12-31	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	7,970	USD	184
2009-06-24 to 2012-12-31	64,954	USD	1287
2011-07-01 to 2011-12-31	2,384	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Unit	Days
2012-07-01 to 2012-12-31	USD	184
2009-06-24 to 2012-12-31	USD	1287
2011-07-01 to 2011-12-31	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-3,250	USD	92
2012-07-01 to 2012-12-31	-7,405	USD	184
2009-06-24 to 2012-12-31	-65,008	USD	1287
2011-10-01 to 2011-12-31	-10,916	USD	92
2011-07-01 to 2011-12-31	-14,774	USD	184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	3,250	USD	92
2012-07-01 to 2012-12-31	7,405	USD	184
2009-06-24 to 2012-12-31	65,008	USD	1287
2011-10-01 to 2011-12-31	10,916	USD	92
2011-07-01 to 2011-12-31	14,774	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	3,944,000	shares
At 2012-06-30	3,944,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-12-31	45,556	USD
At 2012-06-30	45,556	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	-87	USD
At 2012-06-30	-87	USD

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	0	USD	184
2009-06-24 to 2012-12-31	49,500	USD	1287
2011-07-01 to 2011-12-31	0	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	0	USD	184
2009-06-24 to 2012-12-31	0	USD	1287
2011-07-01 to 2011-12-31	5,000	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	1,620	USD	184
2009-06-24 to 2012-12-31	4,120	USD	1287
2011-07-01 to 2011-12-31	2,500	USD	184

Inspect the source

Entity: TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
Captured: 2026-09-20T09:11:11.339Z
SEC response SHA-256: cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))